Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 32 entries
Sorted by: Best Match Show Resources per page
Correction for Henson et al., Artificial Seawater Media Facilitate Cultivating Members of the Microbial Majority from the Gulf of Mexico.

mSphere

Henson MW, Pitre DM, Weckhorst JL, Lanclos VC, Webber AT, Thrash JC.
PMID: 27306839
mSphere. 2016 Jun 01;1(3). doi: 10.1128/mSphere.00124-16. eCollection 2016.

[This corrects the article DOI: 10.1128/mSphere.00028-16.].

Cite
Henson MW, Pitre DM, Weckhorst JL, et al. Correction for Henson et al., Artificial Seawater Media Facilitate Cultivating Members of the Microbial Majority from the Gulf of Mexico. mSphere. 2016;1(3)doi: 10.1128/mSphere.00124-16.
Henson, M. W., Pitre, D. M., Weckhorst, J. L., Lanclos, V. C., Webber, A. T., & Thrash, J. C. (2016). Correction for Henson et al., Artificial Seawater Media Facilitate Cultivating Members of the Microbial Majority from the Gulf of Mexico. mSphere, 1(3), . https://doi.org/10.1128/mSphere.00124-16
Henson, Michael W, et al. "Correction for Henson et al., Artificial Seawater Media Facilitate Cultivating Members of the Microbial Majority from the Gulf of Mexico." mSphere vol. 1,3 (2016). doi: https://doi.org/10.1128/mSphere.00124-16
Henson MW, Pitre DM, Weckhorst JL, Lanclos VC, Webber AT, Thrash JC. Correction for Henson et al., Artificial Seawater Media Facilitate Cultivating Members of the Microbial Majority from the Gulf of Mexico. mSphere. 2016 Jun 01;1(3). doi: 10.1128/mSphere.00124-16. eCollection 2016. PMID: 27306839; PMCID: PMC4894675.
Copy Download .nbib Format: NLM
Asthma and Obesity in Children Are Independently Associated with Airway Dysanapsis.

Frontiers in pediatrics

Jones MH, Roncada C, Fernandes MTC, Heinzmann-Filho JP, Sarria Icaza EE, Mattiello R, Pitrez PMC, Pinto LA, Stein RT.
PMID: 29326908
Front Pediatr. 2017 Dec 18;5:270. doi: 10.3389/fped.2017.00270. eCollection 2017.

BACKGROUND: An increase in the prevalence of overweight and asthma has been observed. Both conditions affect negatively lung function in adults and children. The aim of this study was to analyze the effect of overweight and asthma on lung...

Cite
Jones MH, Roncada C, Fernandes MTC, et al. Asthma and Obesity in Children Are Independently Associated with Airway Dysanapsis. Front Pediatr. 2017;5:270doi: 10.3389/fped.2017.00270.
Jones, M. H., Roncada, C., Fernandes, M. T. C., Heinzmann-Filho, J. P., Sarria Icaza, E. E., Mattiello, R., Pitrez, P. M. C., Pinto, L. A., & Stein, R. T. (2017). Asthma and Obesity in Children Are Independently Associated with Airway Dysanapsis. Frontiers in pediatrics, 5270. https://doi.org/10.3389/fped.2017.00270
Jones, Marcus H, et al. "Asthma and Obesity in Children Are Independently Associated with Airway Dysanapsis." Frontiers in pediatrics vol. 5 (2017): 270. doi: https://doi.org/10.3389/fped.2017.00270
Jones MH, Roncada C, Fernandes MTC, Heinzmann-Filho JP, Sarria Icaza EE, Mattiello R, Pitrez PMC, Pinto LA, Stein RT. Asthma and Obesity in Children Are Independently Associated with Airway Dysanapsis. Front Pediatr. 2017 Dec 18;5:270. doi: 10.3389/fped.2017.00270. eCollection 2017. PMID: 29326908; PMCID: PMC5741591.
Copy Download .nbib Format: NLM
Technical challenges and limitations of current mouse models of ovarian cancer.

Journal of ovarian research

Garson K, Gamwell LF, Pitre EM, Vanderhyden BC.
PMID: 23190474
J Ovarian Res. 2012 Nov 29;5(1):39. doi: 10.1186/1757-2215-5-39.

The development of genetically engineered models (GEM) of epithelial ovarian cancer (EOC) has been very successful, with well validated models representing high grade and low grade serous adenocarcinomas and endometrioid carcinoma (EC). Most of these models were developed using...

Cite
Garson K, Gamwell LF, Pitre EM, et al. Technical challenges and limitations of current mouse models of ovarian cancer. J Ovarian Res. 2012;5(1):39doi: 10.1186/1757-2215-5-39.
Garson, K., Gamwell, L. F., Pitre, E. M., & Vanderhyden, B. C. (2012). Technical challenges and limitations of current mouse models of ovarian cancer. Journal of ovarian research, 5(1), 39. https://doi.org/10.1186/1757-2215-5-39
Garson, Kenneth, et al. "Technical challenges and limitations of current mouse models of ovarian cancer." Journal of ovarian research vol. 5,1 (2012): 39. doi: https://doi.org/10.1186/1757-2215-5-39
Garson K, Gamwell LF, Pitre EM, Vanderhyden BC. Technical challenges and limitations of current mouse models of ovarian cancer. J Ovarian Res. 2012 Nov 29;5(1):39. doi: 10.1186/1757-2215-5-39. PMID: 23190474; PMCID: PMC3537528.
Copy Download .nbib Format: NLM
Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma.

The journal of allergy and clinical immunology. In practice

Porsbjerg CM, Menzies-Gow AN, Tran TN, Murray RB, Unni B, Audrey Ang SL, Alacqua M, Al-Ahmad M, Al-Lehebi R, Altraja A, Belevskiy AS, Björnsdóttir US, Bourdin A, Busby J, Canonica GW, Christoff GC, Cosio BG, Costello RW, FitzGerald JM, Fonseca JA, Hansen S, Heaney LG, Heffler E, Hew M, Iwanaga T, Jackson DJ, Kocks JWH, Kallieri M, Bruce Ko HK, Koh MS, Larenas-Linnemann D, Lehtimäki LA, Loukides S, Lugogo N, Maspero J, Papaioannou AI, Perez-de-Llano L, Pitrez PM, Popov TA, Rasmussen LM, Rhee CK, Sadatsafavi M, Schmid J, Siddiqui S, Taillé C, Taube C, Torres-Duque CA, Ulrik C, Upham JW, Wang E, Wechsler ME, Bulathsinhala L, Carter V, Chaudhry I, Eleangovan N, Hosseini N, Rowlands MA, Price D, van Boven JF.
PMID: 34990866
J Allergy Clin Immunol Pract. 2022 Jan 03; doi: 10.1016/j.jaip.2021.12.027. Epub 2022 Jan 03.

BACKGROUND: Regulatory bodies have approved five biologics for severe asthma. However, regional differences in accessibility may limit the global potential for personalized medicine.OBJECTIVE: To compare global differences in ease-of-access to biologics.METHODS: In April 2021, national prescription criteria for omalizumab,...

Cite
Porsbjerg CM, Menzies-Gow AN, Tran TN, et al. Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma. J Allergy Clin Immunol Pract. 2022;doi: 10.1016/j.jaip.2021.12.027.
Porsbjerg, C. M., Menzies-Gow, A. N., Tran, T. N., Murray, R. B., Unni, B., Audrey Ang, S. L., Alacqua, M., Al-Ahmad, M., Al-Lehebi, R., Altraja, A., Belevskiy, A. S., Björnsdóttir, U. S., Bourdin, A., Busby, J., Canonica, G. W., Christoff, G. C., Cosio, B. G., Costello, R. W., FitzGerald, J. M., Fonseca, J. A., Hansen, S., Heaney, L. G., Heffler, E., Hew, M., Iwanaga, T., Jackson, D. J., Kocks, J. W. H., Kallieri, M., Bruce Ko, H. K., Koh, M. S., Larenas-Linnemann, D., Lehtimäki, L. A., Loukides, S., Lugogo, N., Maspero, J., Papaioannou, A. I., Perez-de-Llano, L., Pitrez, P. M., Popov, T. A., Rasmussen, L. M., Rhee, C. K., Sadatsafavi, M., Schmid, J., Siddiqui, S., Taillé, C., Taube, C., Torres-Duque, C. A., Ulrik, C., Upham, J. W., Wang, E., Wechsler, M. E., Bulathsinhala, L., Carter, V., Chaudhry, I., Eleangovan, N., Hosseini, N., Rowlands, M. A., Price, D., & van Boven, J. F. (2022). Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma. The journal of allergy and clinical immunology. In practice, . https://doi.org/10.1016/j.jaip.2021.12.027
Porsbjerg, Celeste M, et al. "Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma." The journal of allergy and clinical immunology. In practice vol. (2022). doi: https://doi.org/10.1016/j.jaip.2021.12.027
Porsbjerg CM, Menzies-Gow AN, Tran TN, Murray RB, Unni B, Audrey Ang SL, Alacqua M, Al-Ahmad M, Al-Lehebi R, Altraja A, Belevskiy AS, Björnsdóttir US, Bourdin A, Busby J, Canonica GW, Christoff GC, Cosio BG, Costello RW, FitzGerald JM, Fonseca JA, Hansen S, Heaney LG, Heffler E, Hew M, Iwanaga T, Jackson DJ, Kocks JWH, Kallieri M, Bruce Ko HK, Koh MS, Larenas-Linnemann D, Lehtimäki LA, Loukides S, Lugogo N, Maspero J, Papaioannou AI, Perez-de-Llano L, Pitrez PM, Popov TA, Rasmussen LM, Rhee CK, Sadatsafavi M, Schmid J, Siddiqui S, Taillé C, Taube C, Torres-Duque CA, Ulrik C, Upham JW, Wang E, Wechsler ME, Bulathsinhala L, Carter V, Chaudhry I, Eleangovan N, Hosseini N, Rowlands MA, Price D, van Boven JF. Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma. J Allergy Clin Immunol Pract. 2022 Jan 03; doi: 10.1016/j.jaip.2021.12.027. Epub 2022 Jan 03. PMID: 34990866.
Copy Download .nbib Format: NLM
Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes.

The European respiratory journal

Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, Fleming LJ, Inoue H, Ko FW, Krishnan JA, Levy ML, Lin J, Mortimer K, Pitrez PM, Sheikh A, Yorgancioglu AA, Boulet LP.
PMID: 34667060
Eur Respir J. 2021 Oct 19; doi: 10.1183/13993003.02730-2021. Epub 2021 Oct 19.

The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually updated evidence-based strategy for asthma management and prevention, which can be adapted for local circumstances (e.g., medication availability). This article summarizes key recommendations from GINA 2021,...

Cite
Reddel HK, Bacharier LB, Bateman ED, et al. Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes. Eur Respir J. 2021;doi: 10.1183/13993003.02730-2021.
Reddel, H. K., Bacharier, L. B., Bateman, E. D., Brightling, C. E., Brusselle, G. G., Buhl, R., Cruz, A. A., Duijts, L., Drazen, J. M., FitzGerald, J. M., Fleming, L. J., Inoue, H., Ko, F. W., Krishnan, J. A., Levy, M. L., Lin, J., Mortimer, K., Pitrez, P. M., Sheikh, A., Yorgancioglu, A. A., & Boulet, L. P. (2021). Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes. The European respiratory journal, . https://doi.org/10.1183/13993003.02730-2021
Reddel, Helen K, et al. "Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes." The European respiratory journal vol. (2021). doi: https://doi.org/10.1183/13993003.02730-2021
Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, Fleming LJ, Inoue H, Ko FW, Krishnan JA, Levy ML, Lin J, Mortimer K, Pitrez PM, Sheikh A, Yorgancioglu AA, Boulet LP. Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes. Eur Respir J. 2021 Oct 19; doi: 10.1183/13993003.02730-2021. Epub 2021 Oct 19. PMID: 34667060.
Copy Download .nbib Format: NLM
Modified Shuttle Test Distance Correlates With Peak Oxygen Uptake in Children and Adolescents With Severe Therapy-Resistant Asthma.

Frontiers in physiology

Schiwe D, Heinzmann-Filho JP, Schindel CS, Gheller MF, Campos NE, Pitrez PM, Donadio MVF.
PMID: 31632291
Front Physiol. 2019 Oct 01;10:1245. doi: 10.3389/fphys.2019.01245. eCollection 2019.

INTRODUCTION: Several tests may be used to assess exercise intolerance in severe therapy-resistant asthma (STRA), including the gold standard cardiopulmonary exercise test (CPET) and the modified shuttle test (MST).OBJECTIVE: To correlate the distance achieved in the MST with peak...

Cite
Schiwe D, Heinzmann-Filho JP, Schindel CS, et al. Modified Shuttle Test Distance Correlates With Peak Oxygen Uptake in Children and Adolescents With Severe Therapy-Resistant Asthma. Front Physiol. 2019;10:1245doi: 10.3389/fphys.2019.01245.
Schiwe, D., Heinzmann-Filho, J. P., Schindel, C. S., Gheller, M. F., Campos, N. E., Pitrez, P. M., & Donadio, M. V. F. (2019). Modified Shuttle Test Distance Correlates With Peak Oxygen Uptake in Children and Adolescents With Severe Therapy-Resistant Asthma. Frontiers in physiology, 101245. https://doi.org/10.3389/fphys.2019.01245
Schiwe, Daniele, et al. "Modified Shuttle Test Distance Correlates With Peak Oxygen Uptake in Children and Adolescents With Severe Therapy-Resistant Asthma." Frontiers in physiology vol. 10 (2019): 1245. doi: https://doi.org/10.3389/fphys.2019.01245
Schiwe D, Heinzmann-Filho JP, Schindel CS, Gheller MF, Campos NE, Pitrez PM, Donadio MVF. Modified Shuttle Test Distance Correlates With Peak Oxygen Uptake in Children and Adolescents With Severe Therapy-Resistant Asthma. Front Physiol. 2019 Oct 01;10:1245. doi: 10.3389/fphys.2019.01245. eCollection 2019. PMID: 31632291; PMCID: PMC6779804.
Copy Download .nbib Format: NLM
Second Correction for Henson et al., "Artificial Seawater Media Facilitate Cultivating Members of the Microbial Majority from the Gulf of Mexico".

mSphere

Henson MW, Pitre DM, Weckhorst JL, Lanclos VC, Webber AT, Thrash JC.
PMID: 30111630
mSphere. 2018 Aug 15;3(4). doi: 10.1128/mSphere.00415-18.

No abstract available.

Cite
Henson MW, Pitre DM, Weckhorst JL, et al. Second Correction for Henson et al., "Artificial Seawater Media Facilitate Cultivating Members of the Microbial Majority from the Gulf of Mexico". mSphere. 2018;3(4)doi: 10.1128/mSphere.00415-18.
Henson, M. W., Pitre, D. M., Weckhorst, J. L., Lanclos, V. C., Webber, A. T., & Thrash, J. C. (2018). Second Correction for Henson et al., "Artificial Seawater Media Facilitate Cultivating Members of the Microbial Majority from the Gulf of Mexico". mSphere, 3(4), . https://doi.org/10.1128/mSphere.00415-18
Henson, Michael W, et al. "Second Correction for Henson et al., "Artificial Seawater Media Facilitate Cultivating Members of the Microbial Majority from the Gulf of Mexico"." mSphere vol. 3,4 (2018). doi: https://doi.org/10.1128/mSphere.00415-18
Henson MW, Pitre DM, Weckhorst JL, Lanclos VC, Webber AT, Thrash JC. Second Correction for Henson et al., "Artificial Seawater Media Facilitate Cultivating Members of the Microbial Majority from the Gulf of Mexico". mSphere. 2018 Aug 15;3(4). doi: 10.1128/mSphere.00415-18. PMID: 30111630; PMCID: PMC6094061.
Copy Download .nbib Format: NLM
Acute and chronic exposure to Tyrophagus putrescentiae induces allergic pulmonary response in a murine model.

Asia Pacific allergy

Nuñez NK, da Cunha AA, Dos Santos Dutra M, Barbosa GL, Morassutti AL, de Souza RG, Vargas MH, Antunes GL, Silveira JS, da Silva GL, Pitrez PM.
PMID: 26844220
Asia Pac Allergy. 2016 Jan;6(1):48-55. doi: 10.5415/apallergy.2016.6.1.48. Epub 2016 Jan 27.

BACKGROUND: Tyrophagus putrescentiae (Tp) is a source of aeroallergen that causes allergic diseases.OBJECTIVE: To describe an acute and chronic murine model of allergic asthma with Tp extract with no systemic sensitization and no use of adjuvant.METHODS: Mites from dust...

Cite
Nuñez NK, da Cunha AA, Dos Santos Dutra M, et al. Acute and chronic exposure to Tyrophagus putrescentiae induces allergic pulmonary response in a murine model. Asia Pac Allergy. 2016;6(1):48-55doi: 10.5415/apallergy.2016.6.1.48.
Nuñez, N. K., da Cunha, A. A., Dos Santos Dutra, M., Barbosa, G. L., Morassutti, A. L., de Souza, R. G., Vargas, M. H., Antunes, G. L., Silveira, J. S., da Silva, G. L., & Pitrez, P. M. (2016). Acute and chronic exposure to Tyrophagus putrescentiae induces allergic pulmonary response in a murine model. Asia Pacific allergy, 6(1), 48-55. https://doi.org/10.5415/apallergy.2016.6.1.48
Nuñez, Nailê Karine, et al. "Acute and chronic exposure to Tyrophagus putrescentiae induces allergic pulmonary response in a murine model." Asia Pacific allergy vol. 6,1 (2016): 48-55. doi: https://doi.org/10.5415/apallergy.2016.6.1.48
Nuñez NK, da Cunha AA, Dos Santos Dutra M, Barbosa GL, Morassutti AL, de Souza RG, Vargas MH, Antunes GL, Silveira JS, da Silva GL, Pitrez PM. Acute and chronic exposure to Tyrophagus putrescentiae induces allergic pulmonary response in a murine model. Asia Pac Allergy. 2016 Jan;6(1):48-55. doi: 10.5415/apallergy.2016.6.1.48. Epub 2016 Jan 27. PMID: 26844220; PMCID: PMC4731481.
Copy Download .nbib Format: NLM
Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes.

Respirology (Carlton, Vic.)

Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, Fleming LJ, Inoue H, Ko FW, Krishnan JA, Levy ML, Lin J, Mortimer K, Pitrez PM, Sheikh A, Yorgancioglu AA, Boulet LP.
PMID: 34668278
Respirology. 2021 Oct 19; doi: 10.1111/resp.14174. Epub 2021 Oct 19.

The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually updated evidence-based strategy for asthma management and prevention, which can be adapted for local circumstances (e.g., medication availability). This article summarizes key recommendations from GINA 2021,...

Cite
Reddel HK, Bacharier LB, Bateman ED, et al. Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes. Respirology. 2021;doi: 10.1111/resp.14174.
Reddel, H. K., Bacharier, L. B., Bateman, E. D., Brightling, C. E., Brusselle, G. G., Buhl, R., Cruz, A. A., Duijts, L., Drazen, J. M., FitzGerald, J. M., Fleming, L. J., Inoue, H., Ko, F. W., Krishnan, J. A., Levy, M. L., Lin, J., Mortimer, K., Pitrez, P. M., Sheikh, A., Yorgancioglu, A. A., & Boulet, L. P. (2021). Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes. Respirology (Carlton, Vic.), . https://doi.org/10.1111/resp.14174
Reddel, Helen K, et al. "Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes." Respirology (Carlton, Vic.) vol. (2021). doi: https://doi.org/10.1111/resp.14174
Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, Fleming LJ, Inoue H, Ko FW, Krishnan JA, Levy ML, Lin J, Mortimer K, Pitrez PM, Sheikh A, Yorgancioglu AA, Boulet LP. Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes. Respirology. 2021 Oct 19; doi: 10.1111/resp.14174. Epub 2021 Oct 19. PMID: 34668278.
Copy Download .nbib Format: NLM
Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes.

The journal of allergy and clinical immunology. In practice

Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, Fleming LJ, Inoue H, Ko FW, Krishnan JA, Levy ML, Lin J, Mortimer K, Pitrez PM, Sheikh A, Yorgancioglu AA, Boulet LP.
PMID: 34718211
J Allergy Clin Immunol Pract. 2021 Oct 27; doi: 10.1016/j.jaip.2021.10.001. Epub 2021 Oct 27.

The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually updated evidence-based strategy for asthma management and prevention, which can be adapted for local circumstances (e.g., medication availability). This article summarizes key recommendations from GINA 2021,...

Cite
Reddel HK, Bacharier LB, Bateman ED, et al. Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes. J Allergy Clin Immunol Pract. 2021;doi: 10.1016/j.jaip.2021.10.001.
Reddel, H. K., Bacharier, L. B., Bateman, E. D., Brightling, C. E., Brusselle, G. G., Buhl, R., Cruz, A. A., Duijts, L., Drazen, J. M., FitzGerald, J. M., Fleming, L. J., Inoue, H., Ko, F. W., Krishnan, J. A., Levy, M. L., Lin, J., Mortimer, K., Pitrez, P. M., Sheikh, A., Yorgancioglu, A. A., & Boulet, L. P. (2021). Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes. The journal of allergy and clinical immunology. In practice, . https://doi.org/10.1016/j.jaip.2021.10.001
Reddel, Helen K, et al. "Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes." The journal of allergy and clinical immunology. In practice vol. (2021). doi: https://doi.org/10.1016/j.jaip.2021.10.001
Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, Fleming LJ, Inoue H, Ko FW, Krishnan JA, Levy ML, Lin J, Mortimer K, Pitrez PM, Sheikh A, Yorgancioglu AA, Boulet LP. Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes. J Allergy Clin Immunol Pract. 2021 Oct 27; doi: 10.1016/j.jaip.2021.10.001. Epub 2021 Oct 27. PMID: 34718211.
Copy Download .nbib Format: NLM
2021 Brazilian Thoracic Association recommendations for the management of severe asthma.

Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia

Carvalho-Pinto RM, Cançado JED, Pizzichini MMM, Fiterman J, Rubin AS, Cerci Neto A, Cruz ÁA, Fernandes ALG, Araujo AMS, Blanco DC, Cordeiro Junior G, Caetano LSB, Rabahi MF, Menezes MB, Oliveira MA, Lima MA, Pitrez PM.
PMID: 34932721
J Bras Pneumol. 2021 Dec 15;47(6):e20210273. doi: 10.36416/1806-3756/e20210273. eCollection 2021.

Advances in the understanding that severe asthma is a complex and heterogeneous disease and in the knowledge of the pathophysiology of asthma, with the identification of different phenotypes and endotypes, have allowed new approaches for the diagnosis and characterization...

Cite
Carvalho-Pinto RM, Cançado JED, Pizzichini MMM, et al. 2021 Brazilian Thoracic Association recommendations for the management of severe asthma. J Bras Pneumol. 2021;47(6):e20210273doi: 10.36416/1806-3756/e20210273.
Carvalho-Pinto, R. M., Cançado, J. E. D., Pizzichini, M. M. M., Fiterman, J., Rubin, A. S., Cerci Neto, A., Cruz, �. �. A., Fernandes, A. L. G., Araujo, A. M. S., Blanco, D. C., Cordeiro Junior, G., Caetano, L. S. B., Rabahi, M. F., Menezes, M. B., Oliveira, M. A., Lima, M. A., & Pitrez, P. M. (2021). 2021 Brazilian Thoracic Association recommendations for the management of severe asthma. Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia, 47(6), e20210273. https://doi.org/10.36416/1806-3756/e20210273
Carvalho-Pinto, Regina Maria de, et al. "2021 Brazilian Thoracic Association recommendations for the management of severe asthma." Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia vol. 47,6 (2021): e20210273. doi: https://doi.org/10.36416/1806-3756/e20210273
Carvalho-Pinto RM, Cançado JED, Pizzichini MMM, Fiterman J, Rubin AS, Cerci Neto A, Cruz ÁA, Fernandes ALG, Araujo AMS, Blanco DC, Cordeiro Junior G, Caetano LSB, Rabahi MF, Menezes MB, Oliveira MA, Lima MA, Pitrez PM. 2021 Brazilian Thoracic Association recommendations for the management of severe asthma. J Bras Pneumol. 2021 Dec 15;47(6):e20210273. doi: 10.36416/1806-3756/e20210273. eCollection 2021. Portuguese. PMID: 34932721.
Copy Download .nbib Format: NLM
Low performance of a SARS-CoV-2 point-of-care lateral flow immunoassay in symptomatic children during the pandemic.

Jornal de pediatria

Scotta MC, David CN, Varela FH, Sartor ITS, Polese-Bonatto M, Fernandes IR, Zavaglia GO, Ferreira CF, Kern LB, Santos AP, Krauzer JRM, Pitrez PM, Almeida WAF, Porto VBG, Stein RT.
PMID: 34153236
J Pediatr (Rio J). 2021 Jun 03; doi: 10.1016/j.jped.2021.04.010. Epub 2021 Jun 03.

OBJECTIVE: to evaluate the accuracy of an antibody point-of-care lateral flow immunoassay (LFI - Wondfo Biotech Co., Guangzhou, China) in a pediatric population.METHODS: children and adolescents (2 months to 18 years) with signs and symptoms suggestive of acute SARS-CoV-2...

Cite
Scotta MC, David CN, Varela FH, et al. Low performance of a SARS-CoV-2 point-of-care lateral flow immunoassay in symptomatic children during the pandemic. J Pediatr (Rio J). 2021;doi: 10.1016/j.jped.2021.04.010.
Scotta, M. C., David, C. N., Varela, F. H., Sartor, I. T. S., Polese-Bonatto, M., Fernandes, I. R., Zavaglia, G. O., Ferreira, C. F., Kern, L. B., Santos, A. P., Krauzer, J. R. M., Pitrez, P. M., Almeida, W. A. F., Porto, V. B. G., Stein, R. T. (2021). Low performance of a SARS-CoV-2 point-of-care lateral flow immunoassay in symptomatic children during the pandemic. Jornal de pediatria, . https://doi.org/10.1016/j.jped.2021.04.010
Scotta, Marcelo Comerlato, et al. "Low performance of a SARS-CoV-2 point-of-care lateral flow immunoassay in symptomatic children during the pandemic." Jornal de pediatria vol. (2021). doi: https://doi.org/10.1016/j.jped.2021.04.010
Scotta MC, David CN, Varela FH, Sartor ITS, Polese-Bonatto M, Fernandes IR, Zavaglia GO, Ferreira CF, Kern LB, Santos AP, Krauzer JRM, Pitrez PM, Almeida WAF, Porto VBG, Stein RT. Low performance of a SARS-CoV-2 point-of-care lateral flow immunoassay in symptomatic children during the pandemic. J Pediatr (Rio J). 2021 Jun 03; doi: 10.1016/j.jped.2021.04.010. Epub 2021 Jun 03. PMID: 34153236; PMCID: PMC8173459.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 32 entries